Carolyn Stull, Michael J Lavery, Gil Yosipovitch. Expert Opin Pharmacother 2016
Times Cited: 15
Times Cited: 15
Times Cited
Times Co-cited
Similarity
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K Mollanazar, Peter K Smith, Gil Yosipovitch. Clin Rev Allergy Immunol 2016
Nicholas K Mollanazar, Peter K Smith, Gil Yosipovitch. Clin Rev Allergy Immunol 2016
40
Clinical classification of itch: a position paper of the International Forum for the Study of Itch.
Sonja Ständer, Elke Weisshaar, Thomas Mettang, Jacek C Szepietowski, Earl Carstens, Akihiko Ikoma, Nora V Bergasa, Uwe Gieler, Laurent Misery, Joanna Wallengren,[...]. Acta Derm Venereol 2007
Sonja Ständer, Elke Weisshaar, Thomas Mettang, Jacek C Szepietowski, Earl Carstens, Akihiko Ikoma, Nora V Bergasa, Uwe Gieler, Laurent Misery, Joanna Wallengren,[...]. Acta Derm Venereol 2007
40
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
Jeffrey M Sobell, Peter Foley, Darryl Toth, Ulrich Mrowietz, Giampiero Girolomoni, Joana Goncalves, Robert M Day, Rongdean Chen, Gil Yosipovitch. Acta Derm Venereol 2016
Jeffrey M Sobell, Peter Foley, Darryl Toth, Ulrich Mrowietz, Giampiero Girolomoni, Joana Goncalves, Robert M Day, Rongdean Chen, Gil Yosipovitch. Acta Derm Venereol 2016
33
33
The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.
G Yosipovitch, A Goon, J Wee, Y H Chan, C L Goh. Br J Dermatol 2000
G Yosipovitch, A Goon, J Wee, Y H Chan, C L Goh. Br J Dermatol 2000
26
Current topical and systemic therapies for itch.
Tabi Anika Leslie, Malcolm W Greaves, Gil Yosipovitch. Handb Exp Pharmacol 2015
Tabi Anika Leslie, Malcolm W Greaves, Gil Yosipovitch. Handb Exp Pharmacol 2015
26
The neurobiology of itch.
Akihiko Ikoma, Martin Steinhoff, Sonja Ständer, Gil Yosipovitch, Martin Schmelz. Nat Rev Neurosci 2006
Akihiko Ikoma, Martin Steinhoff, Sonja Ständer, Gil Yosipovitch, Martin Schmelz. Nat Rev Neurosci 2006
26
Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
Sonja Ständer, Dorothee Siepmann, Ilka Herrgott, Cord Sunderkötter, Thomas A Luger. PLoS One 2010
Sonja Ständer, Dorothee Siepmann, Ilka Herrgott, Cord Sunderkötter, Thomas A Luger. PLoS One 2010
26
Mirtazapine for pruritus.
Mellar P Davis, Jan L Frandsen, Declan Walsh, Steven Andresen, Sandy Taylor. J Pain Symptom Manage 2003
Mellar P Davis, Jan L Frandsen, Declan Walsh, Steven Andresen, Sandy Taylor. J Pain Symptom Manage 2003
20
Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
Jennifer L Hundley, Gil Yosipovitch. J Am Acad Dermatol 2004
Jennifer L Hundley, Gil Yosipovitch. J Am Acad Dermatol 2004
20
Psychological Interventions in the Treatment of Chronic Itch.
Christina Schut, Nicholas K Mollanazar, Jörg Kupfer, Uwe Gieler, Gil Yosipovitch. Acta Derm Venereol 2016
Christina Schut, Nicholas K Mollanazar, Jörg Kupfer, Uwe Gieler, Gil Yosipovitch. Acta Derm Venereol 2016
20
Butorphanol for treatment of intractable pruritus.
Aerlyn G Dawn, Gil Yosipovitch. J Am Acad Dermatol 2006
Aerlyn G Dawn, Gil Yosipovitch. J Am Acad Dermatol 2006
20
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest,[...]. Lancet 2015
Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest,[...]. Lancet 2015
20
Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand. Acta Derm Venereol 2015
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand. Acta Derm Venereol 2015
20
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Andreas E Kremer, Remco van Dijk, Pamela Leckie, Frank G Schaap, Edith M M Kuiper, Thomas Mettang, Katrin S Reiners, Ulrike Raap, Henk R van Buuren, Karel J van Erpecum,[...]. Hepatology 2012
Andreas E Kremer, Remco van Dijk, Pamela Leckie, Frank G Schaap, Edith M M Kuiper, Thomas Mettang, Katrin S Reiners, Ulrike Raap, Henk R van Buuren, Karel J van Erpecum,[...]. Hepatology 2012
20
Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.
Leigh A Nattkemper, Maria-Estela Martinez-Escala, Ari B Gelman, Elisha M Singer, Alain H Rook, Joan Guitart, Gil Yosipovitch. Acta Derm Venereol 2016
Leigh A Nattkemper, Maria-Estela Martinez-Escala, Ari B Gelman, Elisha M Singer, Alain H Rook, Joan Guitart, Gil Yosipovitch. Acta Derm Venereol 2016
20
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Thomas Ruzicka, Jon M Hanifin, Masutaka Furue, Grazyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida,[...]. N Engl J Med 2017
Thomas Ruzicka, Jon M Hanifin, Masutaka Furue, Grazyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida,[...]. N Engl J Med 2017
20
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call, Lawrence F Eichenfield, Douglass W Forsha, William C Rees, Eric L Simpson,[...]. J Am Acad Dermatol 2016
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call, Lawrence F Eichenfield, Douglass W Forsha, William C Rees, Eric L Simpson,[...]. J Am Acad Dermatol 2016
20
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, Lisa A Beck, Andrew Blauvelt, Michael J Cork, Jonathan I Silverberg, Mette Deleuran, Yoko Kataoka, Jean-Philippe Lacour,[...]. N Engl J Med 2016
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, Lisa A Beck, Andrew Blauvelt, Michael J Cork, Jonathan I Silverberg, Mette Deleuran, Yoko Kataoka, Jean-Philippe Lacour,[...]. N Engl J Med 2016
20
Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.
Martin Steinhoff, John Bienenstock, Martin Schmelz, Marcus Maurer, Ed Wei, Tamás Bíró. J Invest Dermatol 2006
Martin Steinhoff, John Bienenstock, Martin Schmelz, Marcus Maurer, Ed Wei, Tamás Bíró. J Invest Dermatol 2006
13
Chronic pruritus in the elderly: pathophysiology, diagnosis and management.
Rodrigo Valdes-Rodriguez, Carolyn Stull, Gil Yosipovitch. Drugs Aging 2015
Rodrigo Valdes-Rodriguez, Carolyn Stull, Gil Yosipovitch. Drugs Aging 2015
13
Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Ronald L Pisoni, Björn Wikström, Stacey J Elder, Tadao Akizawa, Yashushi Asano, Marcia L Keen, Rajiv Saran, David C Mendelssohn, Eric W Young, Friedrich K Port. Nephrol Dial Transplant 2006
Ronald L Pisoni, Björn Wikström, Stacey J Elder, Tadao Akizawa, Yashushi Asano, Marcia L Keen, Rajiv Saran, David C Mendelssohn, Eric W Young, Friedrich K Port. Nephrol Dial Transplant 2006
13
Clinical characteristics of pruritus in chronic idiopathic urticaria.
G Yosipovitch, N Ansari, A Goon, Y H Chan, C L Goh. Br J Dermatol 2002
G Yosipovitch, N Ansari, A Goon, Y H Chan, C L Goh. Br J Dermatol 2002
13
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes.
José L Jimenez, Miguel A Iñiguez, M Angeles Muñoz-Fernández, Manuel Fresno. Cell Signal 2004
José L Jimenez, Miguel A Iñiguez, M Angeles Muñoz-Fernández, Manuel Fresno. Cell Signal 2004
13
Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.
L T Zane, S Chanda, K Jarnagin, D B Nelson, L Spelman, Lf Stein Gold. Immunotherapy 2016
L T Zane, S Chanda, K Jarnagin, D B Nelson, L Spelman, Lf Stein Gold. Immunotherapy 2016
13
A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves.
Hisashi Wakita, Masayoshi Ohkuro, Naoto Ishii, Ieharu Hishinuma, Manabu Shirato. Exp Dermatol 2015
Hisashi Wakita, Masayoshi Ohkuro, Naoto Ishii, Ieharu Hishinuma, Manabu Shirato. Exp Dermatol 2015
16
Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.
J M Hanifin, S C Chan, J B Cheng, S J Tofte, W R Henderson, D S Kirby, E S Weiner. J Invest Dermatol 1996
J M Hanifin, S C Chan, J B Cheng, S J Tofte, W R Henderson, D S Kirby, E S Weiner. J Invest Dermatol 1996
13
A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology.
Farah Moustafa, Steven R Feldman. Dermatol Online J 2014
Farah Moustafa, Steven R Feldman. Dermatol Online J 2014
13
Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
Tsugunobu Andoh, Tetsuro Yoshida, Yasushi Kuraishi. Exp Dermatol 2014
Tsugunobu Andoh, Tetsuro Yoshida, Yasushi Kuraishi. Exp Dermatol 2014
13
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.
P H Schafer, A Parton, L Capone, D Cedzik, H Brady, J F Evans, H-W Man, G W Muller, D I Stirling, R Chopra. Cell Signal 2014
P H Schafer, A Parton, L Capone, D Cedzik, H Brady, J F Evans, H-W Man, G W Muller, D I Stirling, R Chopra. Cell Signal 2014
13
Topical capsaicin. The fire of a 'hot' medicine is reignited.
Alexandru D P Papoiu, Gil Yosipovitch. Expert Opin Pharmacother 2010
Alexandru D P Papoiu, Gil Yosipovitch. Expert Opin Pharmacother 2010
13
Application of the Itch Severity Score in patients with moderate-to-severe plaque psoriasis: Clinically important difference and responder analyses.
Carla M Mamolo, Andrew G Bushmakin, Joseph C Cappelleri. J Dermatolog Treat 2015
Carla M Mamolo, Andrew G Bushmakin, Joseph C Cappelleri. J Dermatolog Treat 2015
13
Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
Alice Gottlieb, Jingyuan Feng, David J Harrison, Denise Globe. J Am Acad Dermatol 2010
Alice Gottlieb, Jingyuan Feng, David J Harrison, Denise Globe. J Am Acad Dermatol 2010
13
Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.
Jenna L O'Neill, Yiong Huak Chan, Stephen R Rapp, Gil Yosipovitch. Acta Derm Venereol 2011
Jenna L O'Neill, Yiong Huak Chan, Stephen R Rapp, Gil Yosipovitch. Acta Derm Venereol 2011
13
Pruritus is an important factor negatively influencing the well-being of psoriatic patients.
Adam Reich, Ewa Hrehorów, Jacek C Szepietowski. Acta Derm Venereol 2010
Adam Reich, Ewa Hrehorów, Jacek C Szepietowski. Acta Derm Venereol 2010
13
Treatment of pruritic diseases with topical calcineurin inhibitors.
Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar. Ther Clin Risk Manag 2006
Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar. Ther Clin Risk Manag 2006
13
Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.
Joaquín Sola-Ortigosa, Manuel Sánchez-Regaña, Pablo Umbert-Millet. J Dermatolog Treat 2012
Joaquín Sola-Ortigosa, Manuel Sánchez-Regaña, Pablo Umbert-Millet. J Dermatolog Treat 2012
13
Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
A B Kimball, A N Naegeli, E Edson-Heredia, C-Y Lin, C Gaich, E Nikaï, K Wyrwich, G Yosipovitch. Br J Dermatol 2016
A B Kimball, A N Naegeli, E Edson-Heredia, C-Y Lin, C Gaich, E Nikaï, K Wyrwich, G Yosipovitch. Br J Dermatol 2016
13
The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers.
Emiko Senba, Kimiaki Katanosaka, Hiroki Yajima, Kazue Mizumura. Neurosci Res 2004
Emiko Senba, Kimiaki Katanosaka, Hiroki Yajima, Kazue Mizumura. Neurosci Res 2004
13
Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.
V J Ludbrook, K J Hicks, K E Hanrott, J S Patel, M H Binks, M R Wyres, J Watson, P Wilson, M Simeoni, L A Schifano,[...]. Br J Dermatol 2016
V J Ludbrook, K J Hicks, K E Hanrott, J S Patel, M H Binks, M R Wyres, J Watson, P Wilson, M Simeoni, L A Schifano,[...]. Br J Dermatol 2016
13
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Sophie Hugot, Ruquan You,[...]. J Am Acad Dermatol 2015
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Sophie Hugot, Ruquan You,[...]. J Am Acad Dermatol 2015
13
Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity.
David Roblin, Ro Wickramasinghe, Gil Yosipovitch. J Am Acad Dermatol 2014
David Roblin, Ro Wickramasinghe, Gil Yosipovitch. J Am Acad Dermatol 2014
13
A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis.
K A Papp, M A Menter, M Raman, D Disch, D E Schlichting, C Gaich, W Macias, X Zhang, J M Janes. Br J Dermatol 2016
K A Papp, M A Menter, M Raman, D Disch, D E Schlichting, C Gaich, W Macias, X Zhang, J M Janes. Br J Dermatol 2016
13
Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia.
G Yosipovitch, H I Maibach, M C Rowbotham. Acta Derm Venereol 1999
G Yosipovitch, H I Maibach, M C Rowbotham. Acta Derm Venereol 1999
13
Nocturnal Pruritus: The Battle for a Peaceful Night's Sleep.
Michael Joseph Lavery, Carolyn Stull, Michael Owen Kinney, Gil Yosipovitch. Int J Mol Sci 2016
Michael Joseph Lavery, Carolyn Stull, Michael Owen Kinney, Gil Yosipovitch. Int J Mol Sci 2016
13
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.